Early detection of cancer
- Registration Number
- CTRI/2022/05/042936
- Lead Sponsor
- Strand Life Sciences Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1. Patients with confirmed malignant and benign neoplasms who are eligible for surgical resection, chemotherapy or radiation treatments, as identified by the site Principal Investigator or Co-Investigators through routine clinical care processes.
2. Age- 18 years and above.
3. Patients must have normal laboratory criteria as defined below:
â?? Platelets >100,000/mcL
â?? PTT as per institutional limits
â?? INR as per institutional limits
4. Patients who have not undergone any oncosurgery.
5. Patients who are treatment-naïve.
6. Both men and women of all races and ethnic groups are eligible for this study.
7. Ability to understand and the willingness to sign a written Informed Consent Form.
1. Subjects who have undergone prior chemotherapy, targeted therapy or radiation therapy
2. Subjects with recurrent or relapse cases
3. Patients who have an uncontrolled infection
4. Patients who are receiving any oncology investigational agent(s)
5. Patients who are coagulopathic and are taking blood thinning products
6. Women who are pregnant or suspect they are pregnant and lactating mothers
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method